International Biotechnology (LON:IBT – Get Free Report) insider Alexa Henderson purchased 6,996 shares of the stock in a transaction dated Wednesday, February 19th. The stock was acquired at an average cost of GBX 711 ($8.98) per share, for a total transaction of £49,741.56 ($62,844.67).
International Biotechnology Stock Up 0.6 %
LON IBT opened at GBX 720 ($9.10) on Friday. The company’s 50 day moving average is GBX 702.28 and its 200-day moving average is GBX 691.52. International Biotechnology has a 12-month low of GBX 596 ($7.53) and a 12-month high of GBX 736 ($9.30). The firm has a market cap of £258.63 million, a P/E ratio of 6.87 and a beta of 0.21.
International Biotechnology Increases Dividend
The company also recently announced a dividend, which was paid on Friday, January 24th. Investors of record on Thursday, December 19th were issued a dividend of GBX 15.56 ($0.20) per share. This represents a yield of 2.21%. The ex-dividend date of this dividend was Thursday, December 19th. This is a positive change from International Biotechnology’s previous dividend of $14.50. International Biotechnology’s dividend payout ratio is 27.67%.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Featured Stories
- Five stocks we like better than International Biotechnology
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- DuPont’s Electronics Spinoff: The Start of Something Big
- Options Trading – Understanding Strike Price
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.